A history of poly A sequences: from formation to factors to function
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence fo...
Saved in:
Published in | Progress in Nucleic Acid Research and Molecular Biology Vol. 71; pp. 285 - 389 |
---|---|
Main Author | |
Format | Book Chapter Journal Article |
Language | English |
Published |
United States
Elsevier Science & Technology
2002
|
Subjects | |
Online Access | Get full text |
ISBN | 9780125400718 0125400713 |
ISSN | 0079-6603 |
DOI | 10.1016/S0079-6603(02)71046-5 |
Cover
Abstract | Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3′ end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3′ hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3′ end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3′ end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3′ and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3′ end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3′ end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3′ terminal exons is stimulated by cleavage factors that bind to splicing factors at 3′ splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue. |
---|---|
AbstractList | Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue. Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue. Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a protein. Upon differentiation to Plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated by cleavage factors that bind to splicing factors at 3' splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue. Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3′ end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3′ hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3′ end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3′ end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3′ and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3′ end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3′ end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3′ terminal exons is stimulated by cleavage factors that bind to splicing factors at 3′ splice sites; nuclear export of mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue. |
Author | Edmonds, Mary |
Author_xml | – sequence: 1 givenname: Mary surname: Edmonds fullname: Edmonds, Mary organization: Department of Biological Sciences University of Pittsburgh Pittsburgh, Pennsylvania 15260, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12102557$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtv1DAUhY0o0GmZnwDKCrWLwL3Xr5gNGrW8pEpdAGsrcWw1kMRTO1Np_j3JTGHBBm98bX3n6OqcM3YyxtEz9grhLQKqd98AtCmVAn4BdKkRhCrlE7Y2ugKoQBIphU-PbyQpZhyrE7b6K3vOVkIr0JxQn7J1zj9hPkSVQfWCnSIhkJR6xa43xV2Xp5j2RQzFNvb7YlNkf7_zo_P5fRFSHIoQ01BPXRyLKRahdjOeD-NudMv3S_Ys1H3268f7nP349PH71Zfy5vbz16vNTekF8Kk0FISARjpXk9SBWgoSpOFgaiU9YoMBhNNccRe4aFCoypMmjm1AMpL4OXtz9N2mOG-YJzt02fm-r0cfd9nOIRgujP4viEYKpWFxfP0I7prBt3abuqFOe_snoBmgf5x8E-Mv58cp1b27q7eTT9mSqagiq8QyzaIPR5Gfw3jofLLZdUugbZe8m2wbO4tgl6rtoWq7dGaB7KFqK_lvn4qUIA |
ContentType | Book Chapter Journal Article |
Copyright | 2002 |
Copyright_xml | – notice: 2002 |
DBID | FFUUA CGR CUY CVF ECM EIF NPM 7TM 7U9 H94 7X8 |
DEWEY | 572.8 |
DOI | 10.1016/S0079-6603(02)71046-5 |
DatabaseName | ProQuest Ebook Central - Book Chapters - Demo use only Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISBN | 9780080522661 0080522661 |
Editor | Moldave, Kivie |
Editor_xml | – sequence: 1 fullname: Moldave, Kivie |
EndPage | 389 |
ExternalDocumentID | 12102557 EBC298282_64_298 S0079660302710465 |
Genre | Historical Article Journal Article Review |
GroupedDBID | --K --Z -~X .55 .GJ 0R~ 123 3O- 53G 5RE 85S 8N7 8NA 8NF AAXUO AAYSV ABDPE ABGWT ABMAC ABQQC ABSWN ACGFS ACXMD ADVLN AFFNX AFOST AFTJW AGAMA AHDLI AHMUE AKRWK ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN CS3 DU5 F5P FDB HZ~ H~9 JDP MVM O9- SBF SDK SES SHL WH7 X7M XOL YNT ZGI ZKB ZXP 089 20A 38. A4I A4J AAAAS AABBV AALRI AAORS AAVWF ALOFI ALTAS AZZ BBABE CZZ FFUUA HGY MYL SRW CGR CUY CVF ECM EIF NPM VQA 7TM 7U9 ADXHL H94 7X8 |
ID | FETCH-LOGICAL-e403t-92f440b5cca257f2d2f5059309a65e11b1f04c7363cf34b1468e27231df129523 |
IEDL.DBID | HGY |
ISBN | 9780125400718 0125400713 |
ISSN | 0079-6603 |
IngestDate | Fri Jul 11 01:18:45 EDT 2025 Thu Jul 10 23:21:23 EDT 2025 Wed Feb 19 01:33:24 EST 2025 Mon Sep 01 00:22:14 EDT 2025 Sun Apr 06 06:53:03 EDT 2025 |
IsPeerReviewed | false |
IsScholarly | false |
LCCallNum | QP620.P76eb vol. 71 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-e403t-92f440b5cca257f2d2f5059309a65e11b1f04c7363cf34b1468e27231df129523 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-3 |
OCLC | 476073217 |
PMID | 12102557 |
PQID | EBC298282_64_298 |
PQPubID | 23462 |
PageCount | 105 |
ParticipantIDs | proquest_miscellaneous_71893497 proquest_miscellaneous_19546702 pubmed_primary_12102557 proquest_ebookcentralchapters_298282_64_298 elsevier_sciencedirect_doi_10_1016_S0079_6603_02_71046_5 |
PublicationCentury | 2000 |
PublicationDate | 2002 2002-00-00 20020101 |
PublicationDateYYYYMMDD | 2002-01-01 |
PublicationDate_xml | – year: 2002 text: 2002 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Progress in Nucleic Acid Research and Molecular Biology |
PublicationTitleAlternate | Prog Nucleic Acid Res Mol Biol |
PublicationYear | 2002 |
Publisher | Elsevier Science & Technology |
Publisher_xml | – name: Elsevier Science & Technology |
SSID | ssj0000228916 ssj0027906 |
Score | 1.546542 |
SecondaryResourceType | review_article |
Snippet | Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3′ ends of eukaryotic... Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic... Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukaryotic... |
SourceID | proquest pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 285 |
SubjectTerms | Adenoviridae - genetics Adenoviridae - metabolism Escherichia coli Escherichia coli - genetics Escherichia coli - metabolism History, 20th Century Molecular biology RNA Processing, Post-Transcriptional RNA, Bacterial - genetics RNA, Bacterial - metabolism RNA, Fungal - genetics RNA, Fungal - metabolism RNA, Messenger - genetics RNA, Messenger - history RNA, Messenger - metabolism RNA, Viral - genetics RNA, Viral - metabolism Saccharomyces cerevisiae - genetics Saccharomyces cerevisiae - metabolism Vaccinia virus Vaccinia virus - genetics Vaccinia virus - metabolism Viral Proteins - genetics Viral Proteins - metabolism |
Title | A history of poly A sequences: from formation to factors to function |
URI | https://dx.doi.org/10.1016/S0079-6603(02)71046-5 http://ebookcentral.proquest.com/lib/SITE_ID/reader.action?docID=298282&ppg=298&c=UERG https://www.ncbi.nlm.nih.gov/pubmed/12102557 https://www.proquest.com/docview/19546702 https://www.proquest.com/docview/71893497 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwEB3Bcqm4tIW2W1rqA0JUKMJx7DjubUVLV0X0UIEKJyvJ2tJKbbKC5bB_35lJsisOXHpLLFtWZuLxjD3vDcCRLCuLZl8l6cyaRFemSpwKZaJjWRP9l6kLAjhf_cynN_rHrbndgvMBC0Nplb3t72w6W-u-5ayX5tliPieMryVqSbp4o4tKsw07uHBzKmMw_X63Pmghghf2gYYozHHBTRqd0HDm2cEwieO1npJneC82mJ9uPh5xItVnnjIxT7aw51xU3qouXsIuwRcE4QpQZK9gKzSvYW_SYHD9dyWOBad88ln6HnydiI5veCXaKBbtn5WYiHVy9RdB2BOxhjeKZSv68jz8iDsiNe_DzcW36_Np0pdVSIKW2RJ1EbWWlUHd4XqNaqaiocJ-0pW5CWlapVHq2mZ5VsdMV4TNCsqiHziL6Bxg4PoGRk3bhHcgJDp_wUVZEEm9cqpMAzbMMmNrF2NdjKEYxOOfaNWjwfabBDOUrCfJeqk8S9abMZwO4vR8b9wnq9ad-B68chgsKp9rehrDp3VvXB906VE2oX188MRol1upnu-BanaZdnYMbzut-UVH9OGZXM0Y-_7_P-MAXnD9GD60-QCj5f1j-IhuzLI6hJ3J5a_fl4f8u_4DBsvlUw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BPRRxoaXAlhZ8qKpWVYTj2HHc24qvpQVOINGTlWRtCalNVrAc9t93ZpIs4sCFW2LZsjITj2fseW8Avsiysmj2VZJOrUl0ZarEqVAmOpY10X-ZuiCA8-VVPrnRv27N7QocDVgYSqvsbX9n09la9y2HvTQPZ3d3hPG1RC1JF290UWlW4Y3GzZEI9Cdnf5YHLUTwwj7QEIU5LrhJoxMazjw7GCZxvNZT8gzvxRPmp5uPR3yT6jtPmZhnW9hLLipvVaebsEHwBUG4AhTZO1gJzXvYGjcYXP9biK-CUz75LH0Ljsei4xteiDaKWft3IcZimVz9UxD2RCzhjWLeir48Dz_ijkjNH-Dm9OT6aJL0ZRWSoGU2R11ErWVlUHe4XqOaqmiosJ90ZW5CmlZplLq2WZ7VMdMVYbOCsugHTiM6Bxi4bsNa0zZhF4RE5y-4KAsiqVdOlWnAhmlmbO1irIsRFIN4_DOtejTY_inBDCXrSbJeKs-S9WYEPwZxer437pNV6058D145DBaVzzU9jeBg2RvXB116lE1oHx88MdrlVqqXe6CaXaadHcFOpzU_64g-PJOrGWM_vv4zDuDt5Prywl-cX_3eg3WuJcMHOJ9gbX7_GD6jSzOv9vmX_Q_Nlual |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Nucleic+Acid+Research+and+Molecular+Biology&rft.au=Edmonds%2C+Mary&rft.atitle=A+history+of+poly+A+sequences%3A+from+formation+to+factors+to+function&rft.date=2002-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780125400718&rft.issn=0079-6603&rft.volume=71&rft.spage=285&rft.epage=389&rft_id=info:doi/10.1016%2FS0079-6603%2802%2971046-5&rft.externalDocID=S0079660302710465 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Febookcentral.proquest.com%2Fcovers%2F298282-l.jpg |